How many more beloved TV characters does Peleton have to give a heart attack to before somebody steps in? Jess can’t take it anymore, and we hash out some new deals: Infermedica raises $30 million; Wellster gets a fresh $20 million; Casana the smart toilet seat maker raises $30 million; Babylon buys DaytoDay Health and Higi; Atlas Health raises $40 million. -Matthew Holt
Matthew Holt, how are we not talking about one of the single greatest health tech health crises of our time?
What could that possibly be?
How many more beloved TV characters does Peloton have to give a heart attack too before somebody steps in? I can’t take anymore.
I think the SEC is about step in. Is that for the heart attacks or is that for all the stock sales by the CEO?
Causing a real heart attack but for a whole different group of people. It’s January 26th episode of Health Tech Deals.
Infermedica is a company that started by creating symptom checking and chatbot functionality in Poland back in 2012. It’s spread to delivering that patient-facing diagnosis functionality via API and now as preparation for a physician visit. Today they announce a $30m series B and demo their new product which helps prepare a visit, and integrates into the clinician workflow. I spoke with CEO Piotr Orzechowski and Chief Product Officer Tim Price–Matthew Holt.
Today on Health in 2 Point 00, Jess and I cover all the deals that got overshadowed by the big news of Teladoc and Livongo’s merger. First up is Ginger, the mental health provider which raised $50 million in a D round bringing their total up to $120 million. Infermedica, an AI enabled symptom checker and triage tool, raised $10.25 million in a series A. Next, Xealth landed a $6 million investment from Cerner and LRVHealth, partnering with Cerner and bringing their digital health prescribing tool to Cerner in addition to its current integration with Epic. Finally SOC Telemed is going public through a “reverse” merger with Healthcare Merger Corp. —Matthew Holt
One of Europe’s top health tech startups, Infermedica out of Poland just closed a $3.65M funding round for its suite of tools that help patients figure out the best place to go to get care. It’s a patient-routing / symptom-checker with “AI under the hood” that is delivered via an app, chatbot, and voice application for Alexa. (In fact, they “own” the symptom checker that opens when you ask Alexa to “open symptom checker.”) Piotr Orzechowski talks about the full range of ways Infermedica is engaging patients and how they are scaling up their provider facing products as a result of this influx of funding.
Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.
Today on Health in 2 Point 00, Jess and I are in Helsinki for Health 2.0 HIMSS Europe. In Episode 83, Jess asks me about Roche cheating on mySugr—Roche announced a new partnership with digital diabetes provider GlucoMe, about the new $100 million hospital venture fund in Iowa coming from UnityPoint Health, and about Infermedica’s recent $3.65 million raise for their cool symptom checker complete with an AI chatbot. Stay tuned for more updates from the conference. —Matthew Holt
With .health‘s Jennifer Lannon again running the camera and with guest appearances from Bayer’s Aline Noizet and Health 2.0’s Emily Hagermen, Jessica DaMassa asked me about Health 2.0 Europe, DCtoVC, the other goings on in Stiges, Spain. And yes, filmed in a nice Spanish restaurant over a Rioja or 2–Matthew Holt
Listen to them on Itunes or Spotify
Subscribe to our mailing list
Want to Partner with THCB?
View our Advertisement & Sponsorship Prospectus here